Novel medicament comprising fosaprepitant/SBECD has been approved.
Fosaprepitant has been initially approved in 2008 in the USA. In August, 2023, an improved composition also containing SBECD has
A forum for researchers, students and applicants in the field of cyclodextrin technology
Fosaprepitant has been initially approved in 2008 in the USA. In August, 2023, an improved composition also containing SBECD has